Dr. Hoesley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816
Summary
- Director of Internal Medicine Clerkships
Education & Training
- University of Alabama Medical CenterFellowship, Infectious Disease, 1996 - 1999
- University of Alabama Medical CenterResidency, Internal Medicine, 1992 - 1996
- University of South Florida College of MedicineClass of 1992
Certifications & Licensure
- AL State Medical License 1993 - 2025
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Safety and Acceptability of a Vaginal Microbicide
- Rectal Safety and Acceptability Study of Tenofovir 1% Gel Start of enrollment: 2010 Oct 01
- Safety and Adherence of a Non-medicated Intravaginal Ring (IVR) Start of enrollment: 2011 May 01
- Join now to see all
Publications & Presentations
PubMed
- Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention ...Barbara A Friedland, Holly Gundacker, Sharon L Achilles, Beatrice A Chen, Craig Hoesley
Plos One. 2025-01-01 - Phase I Dose Volume Escalation of Rectally Administered PC-1005 to Assess Safety, Pharmacokinetics, and Antiviral Pharmacodynamics as a Multipurpose Prevention Technol...Ken Ho, Craig Hoesley, Peter L Anderson, Jose A Fernández-Romero, Barbara A Friedland
Journal of Acquired Immune Deficiency Syndromes. 2024-12-01 - 1 citationsA Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention.Sharon A Riddler, Clifton W Kelly, Craig J Hoesley, Ken S Ho, Jeanna M Piper
The Journal of Infectious Diseases. 2024-09-23
Journal Articles
- Improvement of Gram-Negative Susceptibility to Fluoroquinolones After Implementation of a Pre-Authorization Policy for Fluoroquinolone Use: A Decade-Long ExperienceRachael A Lee, Stephen A Moser, Craig J Hoesley, Todd P McCarty, Bernard C Camins, Morgan C Scully, Infection Control and Hospital Epidemiology
- Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal RingsCraig J Hoesley, Beatrice A Chen, Jeanna Piper, Clinical Infectious Diseases
- Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal WomenCraig W Hendrix, Robert A Salata, Mark A Marzinke, Craig J Hoesley, Ian McGowan, Clinical Infectious Diseases
Press Mentions
- Heersink School of Medicine Launches Distinction in Health EquityNovember 19th, 2024
- Researchers Report Trial Results of Rectal Microbicides at HIV R4P Virtual ConferenceFebruary 3rd, 2021
- New Options in HIV Prophylaxis Gain Traction Based on Positive Trial Results—Public Health WatchOctober 10th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: